Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04554212 · ClinicalTrials.gov registry record · NA

Blood Flow Restriction Training After Patellar INStability

A NA study of Wounds and Injuries and Knee Injuries, sponsored by Caitlin Conley.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
4
Study locations

NCT04554212: Recruiting NA study of Wounds and Injuries and Knee Injuries, sponsored by Caitlin Conley.

NCT04554212 is a NA study of Wounds and Injuries and Knee Injuries that is actively recruiting participants, run by Caitlin Conley. The registered enrollment target is 78 participants, below the 501-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (84% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04554212, a NA study of Wounds and Injuries and Knee Injuries, is actively recruiting participants, sponsored by Caitlin Conley.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
4
Study locations

Study Summary

This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called blood flow restriction training (called BFRT) will improve recovery for those with patellar instability.

Primary Outcome

The Norwich Patellar Instability (NPI) Scale is a 19-item scale that asks subjects to rate their perceived patellar instability during different tasks, and has been demonstrated to be a valid and responsive tool for assessing patient-reported outcomes for those being treated conservatively or surgically following patellar dislocation. The NPI is scored on a scale of 0 to 100, with lower scores being indicative of less perceived instability

Interventions

  • DEVICE Blood Flow Restriction Training
  • DEVICE Sham Blood Flow Restriction Training

Study Locations (4)

Kentucky

  • UK Healthcare at Turfland - Lexington
  • University of Kentucky Biomotion Laboratory - Lexington

Massachusetts

  • Center for Sports Performance and Research - Foxborough
  • Foxboro Sports Medicine Clinic - Foxborough

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2020-09-09
Est. Completion 2026-06-30
Phase NA
Caitlin Conley

1 total trials

What NCT04554212 shows while recruiting

NCT04554212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 501-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (84% lower).

The record links to 4 conditions, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which Blood Flow Restriction Training is the first listed.

NCT04554212 reports a single indexed study location in Kentucky, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04554212 about?

NCT04554212 is a clinical study titled "Blood Flow Restriction Training After Patellar INStability". This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called blood flow restriction training (called BFRT) will improve recovery for those with patellar instability.

What is the current status of trial NCT04554212?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2020-09-09. Estimated completion is 2026-06-30.

What conditions does trial NCT04554212 study?

This clinical trial studies the following conditions: Wounds and Injuries, Knee Injuries, Patellar Dislocation, Leg Injury.

What interventions are being tested in trial NCT04554212?

The interventions under investigation include: Blood Flow Restriction Training (DEVICE), Sham Blood Flow Restriction Training (DEVICE).

Who is sponsoring clinical trial NCT04554212?

This trial is sponsored by Caitlin Conley, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04554212 being conducted?

This trial has 4 study locations across Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wounds and Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04554212's enrollment target sits among peer trials

78 21st of 27 higher than 7 of 27 other Wounds and Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Wounds and Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04554212, the US trial registry maintained by the National Library of Medicine. NCT04554212 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.